Cryptotanshinone inhibits lung tumorigenesis and induces apoptosis in cancer cells in vitro and in vivo.

Cryptotanshinone is one of the compounds extracted from the root of Salvia miltiorrhiza Bunge. Unlike other tanshinones, only a small number of studies have focused on cryptotanshinone for medical treatment. In the present study, the A549 lung cancer cell line and xenograft models of human lung tumors were used to assess the anti-cancer effect of cryptotanshinone. The effect of cryptotanshinone on human lung cancer, including growth inhibition, cell cycle arrest and apoptosis factors, were identified in vitro, and inhibition of tumor formation, improvement of body condition as well as pathological apoptotic effects were detected in vivo. These results suggested that cryptotanshinone is a potential drug for the treatment and prevention of human lung cancer.

[1]  A. Yılmaz,et al.  Prognostic significance of micropapillary pattern in lung adenocarcinoma and expression of apoptosis‐related markers: caspase‐3, bcl‐2, and p53 , 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[2]  Xu Yuxian,et al.  Tanshinone II-A Inhibits Invasion and Metastasis of Human Hepatocellular Carcinoma Cells in Vitro and in Vivo , 2009, Tumori.

[3]  K. Lee,et al.  New developments in the chemistry and biology of the bioactive constituents of tanshen , 2007, Medicinal research reviews.

[4]  D. Stocum,et al.  Cell cycle regulation and regeneration. , 2013, Current topics in microbiology and immunology.

[5]  Jia Yu,et al.  Novel microemulsion of tanshinone IIA, isolated from Salvia miltiorrhiza Bunge, exerts anticancer activity through inducing apoptosis in hepatoma cells. , 2013, The American journal of Chinese medicine.

[6]  S. Barillé-Nion,et al.  Regulation of cancer cell survival by BCL2 family members upon prolonged mitotic arrest: opportunities for anticancer therapy. , 2012, Anticancer research.

[7]  C. Cotman,et al.  Caspase-3 activation as a bifurcation point between plasticity and cell death , 2012, Neuroscience Bulletin.

[8]  B. Snel,et al.  Evolution and function of the mitotic checkpoint. , 2012, Developmental cell.

[9]  Min Xu,et al.  Tanshinone IIA reverses the malignant phenotype of SGC7901 gastric cancer cells. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[10]  Jae Heun Lee,et al.  Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells. , 2008, International journal of oncology.

[11]  W. El-Deiry,et al.  p21WAF1 and tumourigenesis: 20 years after , 2013, Current opinion in oncology.

[12]  M. Rebucci,et al.  Molecular aspects of cancer cell resistance to chemotherapy. , 2013, Biochemical pharmacology.

[13]  T. Miyazaki,et al.  Two Distinct Controls of Mitotic Cdk1/Cyclin B1 Activity Requisite for Cell Growth Prior to Cell Division , 2007, Cell cycle.

[14]  Yunyi Yao,et al.  Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[15]  X. Jiang,et al.  Clearing the final hurdles to mitochondrial apoptosis: regulation post cytochrome C release. , 2012, Experimental oncology.

[16]  Z. Darżynkiewicz,et al.  Cytometry of apoptosis. Historical perspective and new advances. , 2012, Experimental oncology.

[17]  A. Cataldi,et al.  Cyclin-Dependent Kinase Modulators and Cancer Therapy , 2012, BioDrugs.

[18]  P. Lyu,et al.  Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells , 2010, Proteomics.

[19]  Jian Yong Wu,et al.  Tanshinone biosynthesis in Salvia miltiorrhiza and production in plant tissue cultures , 2010, Applied Microbiology and Biotechnology.

[20]  Å. Gustafsson,et al.  Mitochondria and Mitophagy: The Yin and Yang of Cell Death Control , 2012, Circulation research.